Study Shows Nivolumab-Chemo Combination Improves Survival in Gastric and Esophageal Cancers The phase 3 CheckMate-649 trial evaluating nivolumab (Opdivo) plus chemotherapy compared to chemotherapy alone as a first-line treatment of gastric and esophageal cancers met its primary endpoints of overall survival (OS) and progression-free survival (PFS), according to a Bristol Myers Squibb press release. Nivolumab […]

Read More

Molecules in urine allow doctors to monitor skin cancer What if you could simply provide a urine sample rather than undergo a painful surgical procedure to find out if your cancer was responding to treatment? It may seem too good to be true, but researchers at Pavol Jozef Šafárik University in Košice, Slovakia, have identified […]

Read More

Health Matters 8/14: Making Prostate Cancer Treatment Safer By Edward M. Soffen, M.D. Did you know that an estimated one 1 of every 9 men in the United States will be diagnosed with prostate cancer during his lifetime? In fact, other than skin cancer, prostate cancer is the most common cancer in American men, according […]

Read More